Injective CEO Eric Chen expects US INJ ETFs to launch sooner than 2027
📌 The Rundown:
• The 21Shares Injective ETF and Canary Staked INJ ETF are the only two active U.S. ETF filings, both targeting the same token but with different exposure models—one spot, one staked.
• A successful filing would unlock institutional capital, boost INJ liquidity, and signal regulatory acceptance, potentially accelerating broader DeFi protocol adoption on Injective.
🎯 Strategic Outlook:
If the U.S. SEC clears either ETF by 2025, Injective could see a surge in on‑chain activity and cross‑chain liquidity, cementing its position as a leading layer‑2 for DeFi and derivatives.
🚀 Top 24H Futures Outperformers:
• $PUMPBTC (+400.6%) — Price: 0.0448
• $GTC (+78.4%) — Price: 0.2042
• $FET (+18.1%) — Price: 0.2657
#TrendingTopic #Write2Earn #Altcoins
📌 The Rundown:
• The 21Shares Injective ETF and Canary Staked INJ ETF are the only two active U.S. ETF filings, both targeting the same token but with different exposure models—one spot, one staked.
• A successful filing would unlock institutional capital, boost INJ liquidity, and signal regulatory acceptance, potentially accelerating broader DeFi protocol adoption on Injective.
🎯 Strategic Outlook:
If the U.S. SEC clears either ETF by 2025, Injective could see a surge in on‑chain activity and cross‑chain liquidity, cementing its position as a leading layer‑2 for DeFi and derivatives.
🚀 Top 24H Futures Outperformers:
• $PUMPBTC (+400.6%) — Price: 0.0448
• $GTC (+78.4%) — Price: 0.2042
• $FET (+18.1%) — Price: 0.2657
#TrendingTopic #Write2Earn #Altcoins
